Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study

BACKGROUND AND AIMS: The COVID-19 risk and disease course in inflammatory bowel disease [IBD] patients remains uncertain. Therefore, we aimed to assess the clinical presentation, disease course, and outcomes of COVID-19 in IBD patients. Second, we determined COVID-19 incidences in IBD patients and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Derikx, Lauranne A A P, Lantinga, Marten A, de Jong, Dirk J, van Dop, Willemijn A, Creemers, Rob H, Römkens, Tessa E H, Jansen, Jeroen M, Mahmmod, Nofel, West, Rachel L, Tan, Adriaan C I T L, Bodelier, Alexander G L, Gorter, Moniek H P, Boekema, Paul J, Halet, Eric R C, Horjus, Carmen S, van Dijk, Maarten A, Hirdes, Meike M C, Epping Stippel, Ludger S M, Jharap, Bindia, Lutgens, Maurice W M D, Russel, Maurice G, Gilissen, Lennard P L, Nauta, Sjoukje, van Bodegraven, Adriaan A, Hoentjen, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665430/
https://www.ncbi.nlm.nih.gov/pubmed/33079178
http://dx.doi.org/10.1093/ecco-jcc/jjaa215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665430/
https://www.ncbi.nlm.nih.gov/pubmed/33079178
http://dx.doi.org/10.1093/ecco-jcc/jjaa215

Ejemplares similares